Our findings support future investigations to test the ability of FKN to recruit CNS precursor cells for enhanced oligodendrocyte genesis in injured or diseased CNS, as well as the contribution of CX3CR1 variants to the development and progression of myelin-related deficits in neurodegenerative and neurodevelopmental disorders. The gene discussed is CX3CL1; the disease is neurodevelopmental disorder.